Darin L. Vanderpool
Impact in
- Oncology top 5%
- Pancreatic and Hepatic Oncology Research
- Colorectal Cancer Treatments and Studies
- Cancer Research top 10%
- Protease and Inhibitor Mechanisms
Papers in
-
- Protein Kinase Regulation and GTPase Signaling 6
- Chemical Synthesis and Analysis 2
- Signaling Pathways in Disease 1
-
- Computational Drug Discovery Methods 3
- Co-authors
- Stephen A. Margosiak (4 shared papers)Chen‐Chen Kan (3 shared papers)Christopher Pinko (3 shared papers)Ping Chen (2 shared papers)Robert J. Almassy (1 shared paper)Hideaki Tsuge (1 shared paper)Richard E. Showalter (2 shared papers)Paul A. Rejto (1 shared paper)
- Journals
- Journal of Medicinal Chemistry (3 papers)Bioorganic & Medicinal Chemistry Letters (2 papers)Biochemistry (2 papers)Nature Medicine (1 paper)ACS Medicinal Chemistry Letters (1 paper)
- Partner nations
- United States
In The Last Decade
Darin L. Vanderpool
15 papers receiving 1.5k citations
Darin L. Vanderpool's Hit Papers
Peers
Comparison fields: 5 of 61
- Oncology 456
- Cancer Research 176
- Molecular Biology 779
- Computational Theory and Mathematics 138
- Epidemiology 160
Countries citing papers authored by Darin L. Vanderpool
This map shows the geographic impact of Darin L. Vanderpool's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Darin L. Vanderpool with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Darin L. Vanderpool more than expected).
Fields of papers citing papers by Darin L. Vanderpool
This network shows the impact of papers produced by Darin L. Vanderpool. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Darin L. Vanderpool. The network helps show where Darin L. Vanderpool may publish in the future.
Co-authors
The 25 scholars most cited alongside Darin L. Vanderpool, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Identification of MRTX1133, a Noncovalent, Potent, and Selective KRAS G12D Inhibitor Hit paper breakdown → | 2021 | 566 |
| 2 | Anti-tumor efficacy of a potent and selective non-covalent KRASG12D inhibitor Hit paper breakdown → | 2022 | 386 |
| 3 | MRTX1719 Is an MTA-Cooperative PRMT5 Inhibitor That Exhibits Synthetic Lethality in Preclinical Models and Patients with MTAP -Deleted Cancer Hit paper breakdown → | 2023 | 152 |
| 4 | 1996 | 132 | |
| 5 | 2004 | 92 | |
| 6 | 2022 | 77 | |
| 7 | 1996 | 73 | |
| 8 | 1995 | 42 | |
| 9 | 2009 | 42 | |
| 10 | 2024 | 23 | |
| 11 | 2016 | 22 | |
| 12 | 2006 | 20 | |
| 13 | 2016 | 15 | |
| 14 | 2014 | 1 | |
| 15 | 2023 | 1 |
About Darin L. Vanderpool
Darin L. Vanderpool is a scholar working on Molecular Biology, Computational Theory and Mathematics, Epidemiology, Materials Chemistry and Oncology, having authored 15 papers that have together received 1.6k indexed citations. Recurring topics across this work include Protein Kinase Regulation and GTPase Signaling (6 papers), Cytomegalovirus and herpesvirus research (3 papers), Computational Drug Discovery Methods (3 papers), Chemical Synthesis and Analysis (2 papers), Enzyme Structure and Function (2 papers), Signaling Pathways in Disease (1 paper), Synthesis and biological activity (1 paper) and Alzheimer's disease research and treatments (1 paper). The work is most often cited by research in Oncology (456 citations), Cancer Research (176 citations), Molecular Biology (779 citations), Computational Theory and Mathematics (138 citations) and Epidemiology (160 citations). Darin L. Vanderpool has collaborated with scholars based in United States. Frequent co-authors include Stephen A. Margosiak, Chen‐Chen Kan, Christopher Pinko, Ping Chen, Robert J. Almassy, Hideaki Tsuge, Richard E. Showalter, Paul A. Rejto, Jerry J. Meng and Brad Condon. Their work appears in journals such as Journal of Medicinal Chemistry, Bioorganic & Medicinal Chemistry Letters, Biochemistry, Nature Medicine and ACS Medicinal Chemistry Letters.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.